Solstice Advanced Materials stock gains 3% on beating Q3 estimates

Solstice Advanced Materials (SOLS) reported Q3 adjusted EPS of $0.80, beating estimates by $0.03, with revenue up 8% YoY to $1.05B. Q4 guidance fell short, but full-year 2026 outlook was raised. Stock rose 3.05% in pre-market trading.

Original reporting
Published Nov 4, 2026, 11:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SOLS
Neutral
high confidence
Mentioned
$SOLS
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SOLSNeutralHigh
01

Why it matters

The earnings beat supports short‑term upside, while the guidance miss may trigger sell‑offs, creating a near‑term trading opportunity.

02

Market read

The report provides fresh earnings data and guidance that can move the stock immediately.

03

What to watch

Potential upside from upcoming contracts in healthcare packaging and refrigerants not reflected in guidance.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Solstice Advanced Materials reported Q3 results with EPS $0.80 vs $0.77 consensus and revenue $1.05 B, but Q4 EPS guidance $0.57‑$0.62 falls short of $0.72 consensus.

Company-level read

Ticker impact

$SOLSNeutralHigh confidence
Context

Q3 earnings beat expectations and Q4 guidance missed consensus, causing a 3% pre‑market price move.

Expected impact

likely downside as investors price in the lower Q4 guidance.

Evidence & confidence

The earnings beat is positive, yet the guidance shortfall is material and directly affects valuation expectations.

Market effects

Specialty materials sector may see modest pressure as guidance suggests slower near‑term demand.

U.S. market participants may adjust exposure to industrial materials stocks.

Limited to investors focused on U.S. industrial and materials equities.

Counterpoint

The Q3 beat could signal a longer‑term growth trend that outweighs short‑term guidance concerns.

Key entities

  • Solstice Advanced Materials Inc.

    Specialty materials producer reporting Q3 earnings.

Related articles

$CMEMed

CME Nears Uranium Storage Deal for Physical Futures Contract

CME Group is nearing a deal with ConverDyn (a joint venture between Solstice Advanced Materials and General Atomics) to store uranium for a physical futures contract. The deal, expected to close by year-end, would involve Solstice managing inventories at its Illinois facility. This follows rising uranium demand and prices, with the spot price up over 10% this year.

$SOLSMed

Solstice Advanced Materials Inc (SOLS) (Q3 2026) Earnings Call Highlights: Record

Solstice Advanced Materials (SOLS) reported Q3 2026 net sales of $1.05B, up 8% YoY, exceeding guidance. Adjusted EBITDA rose 13% to $265M. Electronic materials sales surged 31%, while nuclear backlog grew to $2.6B. The company raised full-year guidance and plans to complete $500M in share repurchases by Q1 2027. Challenges include declines in building solutions and nuclear sales, capacity constraints, and terminated M&A plans.

$SOLSHighAI 8/10

What Solstice Advanced Mat (SOLS) Said on Its Q3 Earnings Call

Solstice Advanced Materials (SOLS) reported Q3 sales of $726M, up 6% YoY, with adjusted EBITDA rising 3% to $251M. Refrigerant sales increased 8%, offsetting residential market weakness. Nuclear backlog reached $2.6B. The company raised its full-year sales and EPS guidance, plans to complete share buybacks by Q1 2027, and is evaluating expansion projects.

$SOLSMedAI 8/10

Solstice Adv. Materials (SOLS) Q3 2026 Earnings Call Transcript

Solstice Adv. Materials (SOLS) reported Q3 2026 net sales of $1.05B, up 8% YoY, and raised full-year guidance. The company completed $100M in share repurchases and plans to finish the remaining $400M by Q1 2027. It highlighted growth in data center and nuclear conversion businesses, with a $2.6B nuclear backlog. Adjusted EBITDA rose 13% to $265M, and adjusted EPS was $0.80.